Literature DB >> 21868761

Loss of transcription factor KLF5 in the context of p53 ablation drives invasive progression of human squamous cell cancer.

Yizeng Yang1, Hiroshi Nakagawa, Marie-Pier Tetreault, Janelle Billig, Noel Victor, Abha Goyal, Antonia R Sepulveda, Jonathan P Katz.   

Abstract

Squamous cell cancers account for more than half of all human cancers, and esophageal cancer is the sixth leading cause of cancer death worldwide. The majority of esophageal squamous cell carcinomas have identifiable p53 mutations, yet the same p53 mutations are found at comparable frequencies in precancerous dysplasia, indicating that transformation requires additional somatic changes yet to be defined. Here, we show that the zinc finger transcription factor Krüppel-like factor 5 (KLF5) transactivates NOTCH1 in the context of p53 mutation or loss. KLF5 loss limited NOTCH1 activity and was sufficient on its own to transform primary human keratinocytes harboring mutant p53, leading to the formation of invasive tumors. Restoration of NOTCH1 blocked transformation of KLF5-deficient and p53-mutant keratinocytes. Although human dysplastic epithelia accumulated KLF5, KLF5 expression was lost concurrently with NOTCH1 in squamous cell cancers. Taken together, these results define KLF5 loss as a critical event in squamous cell transformation and invasion. Our findings suggest that KLF5 may be a useful diagnostic and therapeutic target in esophageal squamous carcinomas and possibly more generally in other cancers associated with p53 loss of function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21868761      PMCID: PMC3193554          DOI: 10.1158/0008-5472.CAN-11-1702

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  54 in total

1.  Intestinal-enriched Krüppel-like factor (Krüppel-like factor 5) is a positive regulator of cellular proliferation.

Authors:  R Sun; X Chen; V W Yang
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

Review 2.  Human papillomavirus oncoproteins: pathways to transformation.

Authors:  Cary A Moody; Laimonis A Laimins
Journal:  Nat Rev Cancer       Date:  2010-07-01       Impact factor: 60.716

Review 3.  Etiology and chemoprevention of esophageal squamous cell carcinoma.

Authors:  G D Stoner; A Gupta
Journal:  Carcinogenesis       Date:  2001-11       Impact factor: 4.944

4.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

Review 5.  Mutant p53 gain-of-function in cancer.

Authors:  Moshe Oren; Varda Rotter
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

6.  Notch(ic)-ER chimeras display hormone-dependent transformation, nuclear accumulation, phosphorylation and CBF1 activation.

Authors:  C Ronchini; A J Capobianco
Journal:  Oncogene       Date:  2000-08-10       Impact factor: 9.867

7.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

Review 8.  Genetic steps in the development of squamous cell carcinoma of the esophagus.

Authors:  A M Mandard; P Hainaut; M Hollstein
Journal:  Mutat Res       Date:  2000-04       Impact factor: 2.433

Review 9.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

10.  Evidence for mesenchymal-like sub-populations within squamous cell carcinomas possessing chemoresistance and phenotypic plasticity.

Authors:  D Basu; T-T K Nguyen; K T Montone; G Zhang; L-P Wang; J A Diehl; A K Rustgi; J T Lee; G S Weinstein; M Herlyn
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

View more
  23 in total

Review 1.  Personalized and targeted therapy of esophageal squamous cell carcinoma: an update.

Authors:  Yongjing Liu; Zhaohui Xiong; Andrea Beasley; Thomas D'Amico; Xiaoxin Luke Chen
Journal:  Ann N Y Acad Sci       Date:  2016-07-11       Impact factor: 5.691

Review 2.  Krüppel-like factors in cancer.

Authors:  Marie-Pier Tetreault; Yizeng Yang; Jonathan P Katz
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

3.  KLF5 activates microRNA 200 transcription to maintain epithelial characteristics and prevent induced epithelial-mesenchymal transition in epithelial cells.

Authors:  Baotong Zhang; Zhiqian Zhang; Siyuan Xia; Changsheng Xing; Xinpei Ci; Xin Li; Ranran Zhao; Sha Tian; Gui Ma; Zhengmao Zhu; Liya Fu; Jin-Tang Dong
Journal:  Mol Cell Biol       Date:  2013-10-14       Impact factor: 4.272

Review 4.  SP and KLF Transcription Factors in Digestive Physiology and Diseases.

Authors:  Chang-Kyung Kim; Ping He; Agnieszka B Bialkowska; Vincent W Yang
Journal:  Gastroenterology       Date:  2017-03-30       Impact factor: 22.682

Review 5.  Squamous Cell Cancers: A Unified Perspective on Biology and Genetics.

Authors:  G Paolo Dotto; Anil K Rustgi
Journal:  Cancer Cell       Date:  2016-05-09       Impact factor: 31.743

6.  Regulation of hypoxia-inducible factor 1α (HIF-1α) by lysophosphatidic acid is dependent on interplay between p53 and Krüppel-like factor 5.

Authors:  Sei-Jung Lee; Yi Ran No; Duyen T Dang; Long H Dang; Vincent W Yang; Hyunsuk Shim; C Chris Yun
Journal:  J Biol Chem       Date:  2013-07-23       Impact factor: 5.157

7.  p53 mutation alters the effect of the esophageal tumor suppressor KLF5 on keratinocyte proliferation.

Authors:  Yizeng Yang; Rohinton S Tarapore; Melissa H Jarmel; Marie-Pier Tetreault; Jonathan P Katz
Journal:  Cell Cycle       Date:  2012-09-18       Impact factor: 4.534

Review 8.  Kruppel-like Pluripotency Factors as Modulators of Cancer Cell Therapeutic Responses.

Authors:  Mark K Farrugia; Daniel B Vanderbilt; Mohamad A Salkeni; J Michael Ruppert
Journal:  Cancer Res       Date:  2016-03-10       Impact factor: 12.701

9.  Interruption of KLF5 acetylation converts its function from tumor suppressor to tumor promoter in prostate cancer cells.

Authors:  Xin Li; Baotong Zhang; Qiao Wu; Xinpei Ci; Ranran Zhao; Zhiqian Zhang; Siyuan Xia; Dan Su; Jie Chen; Gui Ma; Liya Fu; Jin-Tang Dong
Journal:  Int J Cancer       Date:  2014-06-28       Impact factor: 7.396

10.  Multifactorial ERβ and NOTCH1 control of squamous differentiation and cancer.

Authors:  Yang Sui Brooks; Paola Ostano; Seung-Hee Jo; Jun Dai; Spiro Getsios; Piotr Dziunycz; Günther F L Hofbauer; Kara Cerveny; Giovanna Chiorino; Karine Lefort; G Paolo Dotto
Journal:  J Clin Invest       Date:  2014-04-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.